EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes

Roberto Trevisan, Matteo Conti, Stefano Ciardullo

Diabetologia · 2024

DOI: 10.1007/s00125-024-06158-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetologia, 2024. Verfasst von Roberto Trevisan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Surgery, University of Milano Bicocca, Milan, Italy. rtrevisan@asst-pg23.it. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Diabetes Mellitus, Type 2, Insulin. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Milano - Bicocca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the availability of new classes of glucose-lowering drugs that improve glycaemic levels and minimise long-term complications, at least 20–25% of people with type 2 diabetes require insulin therapy. Moreover, a substantial proportion of these individuals do not achieve adequate metabolic control following insulin initiation. This is due to several factors: therapeutic inertia, fear of hypoglycaemia and/or weight gain, poor communication, complexity of insulin titration, and the number of injections needed, with the associated reduced adherence to insulin therapy. Once-weekly insulins provide a unique opportunity to simplify basal insulin therapy and to allow good glycaemic control with a low risk of hypoglycaemia. Several approaches to developing a stable and effective once-weekly insulin have been proposed, but, to date, insulin icodec and basal insulin Fc (insulin efsitora alfa) are the only two formulations for which clinical studies have been reported. The results of Phase I and II studies emphasise both efficacy (in term of glucose levels) and potential risks and adverse events. Phase III studies involving insulin icodec are reassuring regarding the risk of hypoglycaemia compared with daily basal insulin analogues. Despite some concerns raised in ongoing clinical trials, the available data suggest that weekly insulins may also be an option for individuals with type 1 diabetes, especially when adherence is suboptimal. For the first time there is an opportunity to make an important breakthrough in basal insulin therapy, particularly in people with type 2 diabetes, and to improve not only the quality of life of people with diabetes, but also the practice of diabetologists. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoglycemic AgentsDiabetes Mellitus, Type 2InsulinHumansDrug Administration ScheduleBlood GlucoseHypoglycemiaInsulin, Long-Acting

Stichwörter der Autor:innen

AdherenceBIFIcodecInsulinReviewWeekly

Substanzen

Hypoglycemic AgentsInsulinBlood GlucoseInsulin, Long-Acting

Autor:innen und Institutionen

  • Department of Medicine and Surgery, University of Milano Bicocca, Milan, Italy. rtrevisan@asst-pg23.it.
  • Endocrine and Diabetology Unit, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy. rtrevisan@asst-pg23.it.
  • Department of Medicine and Surgery, University of Milano Bicocca, Milan, Italy.
  • Department of Medicine and Rehabilitation, Policlinico di Monza, Monza, Italy.

Förderung

  • Università degli Studi di Milano - Bicocca

Zitieren

APA

Trevisan, R., Conti, M., & Ciardullo, S. (2024). Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes. Diabetologia. https://doi.org/10.1007/s00125-024-06158-9

Vancouver

Trevisan R, Conti M, Ciardullo S. Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes. Diabetologia. 2024. doi:10.1007/s00125-024-06158-9

BibTeX
@article{Trevisan2024,
  author = {Trevisan, Roberto and Conti, Matteo and Ciardullo, Stefano},
  title = {Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes},
  journal = {Diabetologia},
  year = {2024},
  doi = {10.1007/s00125-024-06158-9}
}
Kostenlos starten →